华润医药(03320.HK) 公布，附属东阿阿胶(000423.SZ) 上半年业绩，，营业收入30.51亿人民币(下同)，按年增加11%。归属股东净利润8.18亿元，增长10.7%，每股盈利1.27元。每10股派息12.69元。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-08-21 16:25。) (A股报价延迟最少十五分钟。)
| 公布日期 | 派息事项 | 派息内容 |
|---|---|---|
| 2025/03/26 | 末期业绩 | 股息：人民币 0.0520 (约相等于 0.056 港元, 可选择港币或该等货币组合) |
| 2024/08/29 | 中期业绩 | 股息：人民币 0.0830 (约相等于 0.0908 港元, 可选择港币或该等货币组合) |
| 2024/03/26 | 末期业绩 | 股息：人民币 0.1540 (约相等于 0.1697 港元, 可选择HKD或该等货币组合) |
| 2023/08/31 | 中期业绩 | 无派息 |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.